Last reviewed · How we verify
NCT06238349: HFN
Hyperbilirubinemia in Full-term Neonates
Phase 4 trial testing Oral bifidobacterium triple live powder in Hyperbilirubinemia, Neonatal in 200 participants. Status unknown.
21 June 2024
Quick facts
| Lead sponsor | Zhuhai Center for Maternal and Child Health Care |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 200 |
| Start date | 23 January 2024 |
| Primary completion | 21 June 2024 |
| Estimated completion | 28 June 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Oral bifidobacterium triple live powder — full drug profile →
- Sunbathing
- Sunbathing and the Oral bifidobacterium triple live powder
- Conventional treatment — full drug profile →
Conditions studied
- Hyperbilirubinemia, Neonatal — all drugs for Hyperbilirubinemia, Neonatal →
Sponsor
Zhuhai Center for Maternal and Child Health Care — full company profile →
Who can join
Under 1 Day, any sex, with Hyperbilirubinemia, Neonatal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To evaluate the efficacy and safety of sunbathing and Bifidobacterium alone or in combination for full-term neonates with hyperbilirubinemia. The investigators hypothesize that the combination therapy of sunbathing plus Bifidobacterium is safe and effective for prevention and management of hyperbilirubinemia in full-term neonates. The investigators therefore design this prospective, randomized, controlled study to assess the preventive effects of sunbathing combined with Bifidobacterium supplementation on hyperbilirubinemia in full-term neonates. These observations may provide scientific evidence for the use of sunbathing and Bifidobacterium supplementation in the management of hyperbilirubinemia in full-term neonates.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06238349
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyperbilirubinemia, Neonatal
Currently open trials in the same condition.
- NCT03866213 — Validation of a Jaundice Diagnostic and Monitoring Device for Low-Resource Settings · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06238349 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zhuhai Center for Maternal and Child Health Care
- Last refreshed: 2 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06238349.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing